3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Colorectal Neoplasms
4
Brain Neoplasms
3
Radiodermatitis
2
Pancreatic Neoplasms
2
Pain, Postoperative
2
Lung Neoplasms
2
Leiomyoma
2
Head and Neck Neoplasms
2
Warts
1
Surgical Wound
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Diseases
1
Sigmoid Neoplasms
1
Severe Acute Respiratory Syndrome
1
Sarcoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neuroinflammatory Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Mastocytosis
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Injury
1
Locally Advanced Cervical Cancer
1
Limited Stage Small Cell Lung Cancer
1
Leukemia, Myeloid, Acute
1
Interventions
fludarabine
19
Whole-Body Irradiation
18
Cyclophosphamide
17
fludarabine phosphate
16
ruxolitinib
15
Mycophenolic Acid
14
Specimen Handling
13
Tacrolimus
11
Azacitidine
11
Biopsy
10
Peripheral Blood Stem Cell Transplantation
9
Melphalan
9
Cytarabine
9
venetoclax
8
Sirolimus
8
Busulfan
8
Stem Cell Transplantation
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Daunorubicin
5
Cyclosporine
5
CPX-351
5
luspatercept
4
ivosidenib
4
itacitinib
4
fedratinib
4
decitabine and cedazuridine drug combination
4
Thiotepa
4
Liposomes
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Sodium Chloride
×
1 year
×
Clear all
No trials found.